The primary care pediatric nurse practitioner is performing a medication history on a child and learns that the child's parents use various complementary treatments and remedies for the child. According to the American Academy of Pediatrics standard for providers, what will the nurse practitioner do?

The primary care pediatric nurse practitioner is performing a medication history on a child and learns that the child's parents use various complementary treatments and remedies for the child. According to the American Academy of Pediatrics standard for providers, what will the nurse practitioner do?

• A. Evaluate the safety and efficacy of each product and monitor use.
• B. Incorporate these therapies into standard care practices.
• C. Recommend not using the products until the child is older.
• D. Suggest that most of these treatments are not safe for children.

Answer: (A)

When families use complementary therapies, the clinician’s first responsibility is to gather information and assess safety. The best approach under the American Academy of Pediatrics standards is to evaluate the safety and efficacy of each product and monitor its use. This means looking at the quality of evidence supporting the therapy, any potential side effects, how the therapy might interact with prescribed medications or treatments, appropriate dosing, and contraindications for the child’s age and health conditions. The clinician then documents what’s being used and provides evidence-based guidance, arranging ongoing monitoring for adverse effects or changes in the treatment plan. This approach respects families’ choices while prioritizing the child’s safety and ensuring coordinated care. Rationale for not treating CAM therapies as automatically part of standard care, nor universally advising against them: evidence for many CAM products varies widely, so integration into standard care isn’t appropriate without solid proof. Blanket recommendations to wait until a child is older or to deem all CAM unsafe fail to acknowledge potential benefits and risks on a case-by-case basis, and they can undermine open communication and safe management.

When families use complementary therapies, the clinician’s first responsibility is to gather information and assess safety. The best approach under the American Academy of Pediatrics standards is to evaluate the safety and efficacy of each product and monitor its use. This means looking at the quality of evidence supporting the therapy, any potential side effects, how the therapy might interact with prescribed medications or treatments, appropriate dosing, and contraindications for the child’s age and health conditions. The clinician then documents what’s being used and provides evidence-based guidance, arranging ongoing monitoring for adverse effects or changes in the treatment plan. This approach respects families’ choices while prioritizing the child’s safety and ensuring coordinated care.

Rationale for not treating CAM therapies as automatically part of standard care, nor universally advising against them: evidence for many CAM products varies widely, so integration into standard care isn’t appropriate without solid proof. Blanket recommendations to wait until a child is older or to deem all CAM unsafe fail to acknowledge potential benefits and risks on a case-by-case basis, and they can undermine open communication and safe management.